These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of pyoderma gangrenosum with mycophenolate mofetil as a steroid-sparing agent. Li J, Kelly R. J Am Acad Dermatol; 2013 Oct; 69(4):565-9. PubMed ID: 23850090 [Abstract] [Full Text] [Related]
3. Mycophenolate mofetil as adjunctive therapy to corticosteroids for the treatment of pyoderma gangrenosum: a case series and literature review. Hrin ML, Bashyam AM, Huang WW, Feldman SR. Int J Dermatol; 2021 Dec; 60(12):e486-e492. PubMed ID: 33739458 [Abstract] [Full Text] [Related]
4. Mycophenolate mofetil and cyclosporin treatment for recalcitrant pyoderma gangrenosum. Hohenleutner U, Mohr VD, Michel S, Landthaler M. Lancet; 1997 Dec 13; 350(9093):1748. PubMed ID: 9413469 [No Abstract] [Full Text] [Related]
5. [Therapy-resistant pyoderma gangrenosum--treatment with mycophenolate mofetil and cyclosporine A]. Michel S, Hohenleutner U, Mohr V, Landthaler M. Hautarzt; 1999 Jun 13; 50(6):428-31. PubMed ID: 10427512 [Abstract] [Full Text] [Related]
6. Mycophenolate mofetil in pyoderma gangrenosum. Lee MR, Cooper AJ. J Dermatolog Treat; 2004 Sep 13; 15(5):303-7. PubMed ID: 15370398 [Abstract] [Full Text] [Related]
7. The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum. Nousari HC, Lynch W, Anhalt GJ, Petri M. Arch Dermatol; 1998 Dec 13; 134(12):1509-11. PubMed ID: 9875186 [No Abstract] [Full Text] [Related]
9. Severe recalcitrant pyoderma gangrenosum responding to a combination of mycophenolate mofetil with cyclosporin and complicated by a mononeuritis. Gilmour E, Stewart DG. Br J Dermatol; 2001 Feb 13; 144(2):397-400. PubMed ID: 11251582 [Abstract] [Full Text] [Related]
10. Pyoderma gangrenosum associated with Wegener's granulomatosis: partial response to mycophenolate mofetil. Le Hello C, Bonte I, Mora JJ, Verneuil L, Noël LH, Guillevin L. Rheumatology (Oxford); 2002 Feb 13; 41(2):236-7. PubMed ID: 11886982 [No Abstract] [Full Text] [Related]
11. Mycophenolate use in dermatology: a clinical audit. Li J, Chong AH, Green J, Kelly R, Baker C. Australas J Dermatol; 2013 Nov 13; 54(4):296-302. PubMed ID: 23574297 [Abstract] [Full Text] [Related]
12. Treatment of recalcitrant ulcers in pyoderma gangrenosum with mycophenolate mofetil and autologous keratinocyte transplantation on a hyaluronic acid matrix. Wollina U, Karamfilov T. J Eur Acad Dermatol Venereol; 2000 May 13; 14(3):187-90. PubMed ID: 11032062 [Abstract] [Full Text] [Related]
13. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. Regueiro M, Valentine J, Plevy S, Fleisher MR, Lichtenstein GR. Am J Gastroenterol; 2003 Aug 13; 98(8):1821-6. PubMed ID: 12907338 [Abstract] [Full Text] [Related]
14. [Infliximab for a girl with refractory pyoderma gangrenosum]. Nozawa T, Hara R, Kinoshita J, Sano F, Miyamae T, Imagawa T, Mori M, Hirokado M, Takahashi K, Inayama Y, Yokota S. Nihon Rinsho Meneki Gakkai Kaishi; 2008 Dec 13; 31(6):454-9. PubMed ID: 19122376 [Abstract] [Full Text] [Related]
15. Pyoderma gangrenosum--rebel without a cure? Jacob SE, Weisman RS, Kerdel FA. Int J Dermatol; 2008 Feb 13; 47(2):192-4. PubMed ID: 18211497 [Abstract] [Full Text] [Related]
16. Mycophenolate mofetil and skin diseases. Hartmann M, Enk A. Lupus; 2005 Feb 13; 14 Suppl 1():s58-63. PubMed ID: 15803935 [Abstract] [Full Text] [Related]
18. Pyoderma gangrenosum of the vulva treated with mycophenolate mofetil and infliximab. Sadowsky LM, Clark MA, Schlosser BJ. Dermatol Ther; 2019 May 13; 32(3):e12905. PubMed ID: 30964575 [No Abstract] [Full Text] [Related]
19. Mycophenolate mofetil therapy for inflammatory eye disease. Thorne JE, Jabs DA, Qazi FA, Nguyen QD, Kempen JH, Dunn JP. Ophthalmology; 2005 Aug 13; 112(8):1472-7. PubMed ID: 16061096 [Abstract] [Full Text] [Related]
20. Intravenous cyclosporine therapy in the treatment of pyoderma gangrenosum secondary to Crohn's disease. Carp JM, Onuma E, Das K, Gottlieb AB. Cutis; 1997 Sep 13; 60(3):135-8. PubMed ID: 9314617 [Abstract] [Full Text] [Related] Page: [Next] [New Search]